914 related articles for article (PubMed ID: 21640209)
1. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa.
Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA
J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209
[TBL] [Abstract][Full Text] [Related]
2. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming.
Gutiérrez JM; Lomonte B; León G; Alape-Girón A; Flores-Díaz M; Sanz L; Angulo Y; Calvete JJ
J Proteomics; 2009 Mar; 72(2):165-82. PubMed ID: 19344652
[TBL] [Abstract][Full Text] [Related]
3. Snakebite envenoming from a global perspective: Towards an integrated approach.
Gutiérrez JM; Williams D; Fan HW; Warrell DA
Toxicon; 2010 Dec; 56(7):1223-35. PubMed ID: 19951718
[TBL] [Abstract][Full Text] [Related]
4. Needs and availability of snake antivenoms: relevance and application of international guidelines.
Scheske L; Ruitenberg J; Bissumbhar B
Int J Health Policy Manag; 2015 Apr; 4(7):447-57. PubMed ID: 26188809
[TBL] [Abstract][Full Text] [Related]
5. Omics meets biology: application to the design and preclinical assessment of antivenoms.
Calvete JJ; Sanz L; Pla D; Lomonte B; Gutiérrez JM
Toxins (Basel); 2014 Dec; 6(12):3388-405. PubMed ID: 25517863
[TBL] [Abstract][Full Text] [Related]
6. Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.
Harrison RA; Oluoch GO; Ainsworth S; Alsolaiss J; Bolton F; Arias AS; Gutiérrez JM; Rowley P; Kalya S; Ozwara H; Casewell NR
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005969. PubMed ID: 29045429
[TBL] [Abstract][Full Text] [Related]
7. A Review of the Proteomic Profiling of African Viperidae and Elapidae Snake Venoms and Their Antivenom Neutralisation.
Offor BC; Muller B; Piater LA
Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355973
[TBL] [Abstract][Full Text] [Related]
8. A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming.
Gutiérrez JM; Burnouf T; Harrison RA; Calvete JJ; Kuch U; Warrell DA; Williams DJ;
Bull World Health Organ; 2014 Jul; 92(7):526-32. PubMed ID: 25110378
[TBL] [Abstract][Full Text] [Related]
9. Toxin-resolved antivenomics-guided assessment of the immunorecognition landscape of antivenoms.
Calvete JJ; Rodríguez Y; Quesada-Bernat S; Pla D
Toxicon; 2018 Jun; 148():107-122. PubMed ID: 29704534
[TBL] [Abstract][Full Text] [Related]
10. Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms.
Alomran N; Alsolaiss J; Albulescu LO; Crittenden E; Harrison RA; Ainsworth S; Casewell NR
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009659. PubMed ID: 34407084
[TBL] [Abstract][Full Text] [Related]
11. Immunological profile of antivenoms: preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays.
Gutiérrez JM; Lomonte B; Sanz L; Calvete JJ; Pla D
J Proteomics; 2014 Jun; 105():340-50. PubMed ID: 24583507
[TBL] [Abstract][Full Text] [Related]
12. Current research into snake antivenoms, their mechanisms of action and applications.
Silva A; Isbister GK
Biochem Soc Trans; 2020 Apr; 48(2):537-546. PubMed ID: 32196542
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead.
Gutiérrez JM; Solano G; Pla D; Herrera M; Segura Á; Vargas M; Villalta M; Sánchez A; Sanz L; Lomonte B; León G; Calvete JJ
Toxins (Basel); 2017 May; 9(5):. PubMed ID: 28505100
[TBL] [Abstract][Full Text] [Related]
14. Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
Laustsen AH; Johansen KH; Engmark M; Andersen MR
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005361. PubMed ID: 28158193
[TBL] [Abstract][Full Text] [Related]
15. Antivenom therapy of carpet viper (Echis ocellatus) envenoming: effectiveness and strategies for delivery in West Africa.
Habib AG; Warrell DA
Toxicon; 2013 Jul; 69():82-9. PubMed ID: 23339853
[TBL] [Abstract][Full Text] [Related]
16. Antivenom for snakebite envenoming in Sri Lanka: the need for geographically specific antivenom and improved efficacy.
Keyler DE; Gawarammana I; Gutiérrez JM; Sellahewa KH; McWhorter K; Malleappah R
Toxicon; 2013 Jul; 69():90-7. PubMed ID: 23454626
[TBL] [Abstract][Full Text] [Related]
17. Preclinical efficacy of Australian antivenoms against the venom of the small-eyed snake, Micropechis ikaheka, from Papua New Guinea: an antivenomics and neutralization study.
Pla D; Paiva OK; Sanz L; Beutler M; Wright CE; Calvete JJ; Williams DJ; Gutiérrez JM
J Proteomics; 2014 Oct; 110():198-208. PubMed ID: 24980637
[TBL] [Abstract][Full Text] [Related]
18. Vulnerability to snakebite envenoming: a global mapping of hotspots.
Longbottom J; Shearer FM; Devine M; Alcoba G; Chappuis F; Weiss DJ; Ray SE; Ray N; Warrell DA; Ruiz de Castañeda R; Williams DJ; Hay SI; Pigott DM
Lancet; 2018 Aug; 392(10148):673-684. PubMed ID: 30017551
[TBL] [Abstract][Full Text] [Related]
19. Commercial Antivenoms Exert Broad Paraspecific Immunological Binding and In Vitro Inhibition of Medically Important
Alsolaiss J; Alomran N; Hawkins L; Casewell NR
Toxins (Basel); 2022 Dec; 15(1):. PubMed ID: 36668821
[TBL] [Abstract][Full Text] [Related]
20. Antivenomics and venom phenotyping: A marriage of convenience to address the performance and range of clinical use of antivenoms.
Calvete JJ
Toxicon; 2010 Dec; 56(7):1284-91. PubMed ID: 20036274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
